Top compounds associated with response to SYMPK


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA CD-437 CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA isoevodiamine CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.14 0.0001
Download CSV